Senior Manager, Analytical Development at Vedere Bio - Cambridge, MA, US
Chief Operating Officer
Contact Mark Gaffney
Board Member
Contact Steve Tregay
Scientist II, AAV Cell Line Engineering
Contact Yanjing Li
Senior Director, Program Leader
Contact Daniel PhD
Senior Research Associate/Engineer
Contact Yonatan Abune
Senior Research Associate
Contact Anna Prendeville
Scientist
Contact Silvia Pasini
Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.